Adlai Nortye Ltd. (ANL)
NASDAQ·Healthcare·Biotechnology
$10.35
+3.03%
Mkt Cap $274.57M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$16.00
Range $16.00 – $16.00
Implied Upside
+54.6%
Consensus $16.00 vs current $10.35
NASDAQ·Healthcare·Biotechnology
$10.35
+3.03%
Mkt Cap $274.57M
No recent rating data.
Price Target (2 analysts)
$16.00
Range $16.00 – $16.00
+54.6%
Consensus $16.00 vs current $10.35